Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchodilators in COPD: latest recommendations, recent data and perspectives].

Nicolas Roche1

  • 1Service de pneumologie, Hôpital de l'Hôtel-Dieu, 1, place du Parvis de Notre-Dame 75004 Paris. roche_nicolas@hotmail.com

Presse Medicale (Paris, France : 1983)
|March 18, 2004
PubMed
Summary

Inhaled bronchodilators enhance COPD patient quality of life by reducing symptoms and exacerbations. Treatment choice depends on individual response, as no single bronchodilator class shows superiority.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

American journal of respiratory and critical care medicine·2026
Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026
Same author

Distal Airway Inflammation Is Linked to Small Airway Dysfunction in Asthma.

Medical sciences (Basel, Switzerland)·2026
Same author

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Functional dyspnea as an early marker of vulnerability to persistent physical symptoms in the CONSTANCES population-based cohort.

Journal of psychosomatic research·2026
Same author

Short-term prediction of COPD exacerbations based on wearable vital sign monitoring.

PLOS digital health·2026

Area of Science:

  • Respiratory Medicine
  • Pharmacology

Context:

  • Chronic Obstructive Pulmonary Disease (COPD) significantly impacts patient quality of life.
  • Dyspnea and exacerbation frequency are key indicators of COPD severity and progression.

Purpose:

  • To review the efficacy and therapeutic options for managing COPD symptoms.
  • To guide the selection of inhaled bronchodilators based on individual patient response.

Summary:

  • Inhaled bronchodilators, including beta-2 agonists and anticholinergic agents, effectively reduce dyspnea and exacerbations in COPD patients.
  • Current evidence does not support the superiority of one bronchodilator class over another; individualized symptomatic response dictates treatment choice.
  • Combination therapy with bronchodilators is permissible. Long-acting formulations and phosphodiesterase inhibitors are emerging options. Inhaled corticosteroids may be beneficial for severe, symptomatic cases.

Related Experiment Videos

Impact:

  • Optimizing inhaled bronchodilator selection can improve COPD patient outcomes and quality of life.
  • Understanding the role of adjunctive therapies like theophylline and corticosteroids aids in comprehensive COPD management.
  • Future developments in bronchodilator and anti-inflammatory agents promise enhanced therapeutic strategies for COPD.